Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Pharmacodynamics of Finerenone in Peritoneal Dialysis Patients
ChiCTR2500112969Phase 4Recruiting
- Sponsor
- Fujian Provincial Hospital
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of finerenone in chronic kidney disease (CKD), sponsored by Fujian Provincial Hospital. Primary endpoint: Plasma finerenone concentration. Started Nov 2025; status: recruiting.
02
Drugs
finerenone
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR2500112969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112969.